Postremission gemtuzumab ozogamicin for elderly patients with acute myelogenous leukemia with favorable characteristics and comorbid conditions
- PMID: 20978876
- DOI: 10.1007/s12185-010-0711-9
Postremission gemtuzumab ozogamicin for elderly patients with acute myelogenous leukemia with favorable characteristics and comorbid conditions
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
